Centaurus Financial’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$305K Buy
7,152
+463
+7% +$20.7K 0.01% 746
2026
Q1
$322K Sell
6,689
-326
-5% -$15.2K 0.02% 656
2025
Q4
$340K Sell
7,015
-1,019
-13% -$50.5K 0.02% 643
2025
Q3
$379K Buy
8,034
+2,667
+50% +$129K 0.02% 609
2025
Q2
$259K Buy
5,367
+294
+6% +$15K 0.02% 651
2025
Q1
$281K Buy
5,073
+1,037
+26% +$56.1K 0.02% 592
2024
Q4
$195K Sell
4,036
-154
-4% -$7.83K 0.01% 667
2024
Q3
$241K Sell
4,190
-114
-3% -$6.16K 0.02% 596
2024
Q2
$209K Buy
4,304
+2,193
+104% +$106K 0.01% 597
2024
Q1
$103K Buy
+2,111
New +$103K 0.01% 757
2018
Q3
Sell
-694
Closed -$28K 1815
2018
Q2
$28K Buy
+694
New +$27.3K ﹤0.01% 1142

Other funds holding SNY

Centaurus Financial's SNY Position: Q2 2026 in Review

Centaurus Financial increased its Sanofi (SNY) stake by 6.9% in Q2 2026, buying an estimated $20.7K and bringing the position to 7,152 shares worth $305K. The position accounts for 0.01% of the portfolio, ranked #746.

Centaurus Financial first reported a position in SNY in Q2 2018 and has held it in 11 quarters since. The position peaked at $379K in Q3 2025. 716 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Centaurus Financial held 7,152 shares of Sanofi worth $305K as of Q2 2026.
  • Centaurus Financial bought 463 Sanofi shares in Q2 2026, an estimated $20.7K.
  • Sanofi made up 0.01% of Centaurus Financial's portfolio in Q2 2026, its #746 holding.
  • Centaurus Financial first reported a position in Sanofi in Q2 2018 and has held it in 11 quarters since.
  • Centaurus Financial's Sanofi position peaked at $379K in Q3 2025.
  • 716 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Centaurus Financial's 13F filing for Q2 2026, filed 17 Aug 2026.